Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and ...

Shares of Eli Lilly & Co. LLY advanced 1.11% to $915.04 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 and ...

Are you struggling to guess the answer to today’s Worldle, 20 September? Don’t worry – we’re here to help you. Worldle isn’t a typo, oh no. This geography-based daily game is a riff on ...

Brittany Cartwright Reveals Cosmetic Procedure She Had Done Before Jax Taylor Divorce ...

Something went wrong. Try again, or contact support if the problem persists. Your details are incorrect, or aren't in our system yet. Please try again, or sign up if you're new here.